NEWS: 日商环球讯息有限公司台湾分公司很高兴地宣布,已在近日完成更改域名,以提供各位顾客更好的服务。我们的最新网域名是https://cn.gii.tw/
表纸
市场调查报告书
商品编码
1145575

抗真菌药物市场:2022-2027 年全球行业趋势、份额、规模、增长、机遇和预测

Antifungal Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

出版日期: | 出版商: IMARC Services Private Limited | 英文 141 Pages | 商品交期: 2-3个工作天内

价格

到 2021 年,全球抗真菌药物市场规模将达到 140 亿美元。展望未来,IMARC Group 预测 2027 年将达到 174 亿美元,2022 年至 2027 年期间的增长率 (CAGR) 为 3.7%。鑑于 COVID-19 的不确定性,我们不断跟踪和评估大流行的直接和间接影响。这些见解作为市场的主要贡献者包含在报告中。

抗真菌剂(抗真菌剂)是指用于治疗皮肤、头髮和指甲真菌感染的药物。常用的抗真菌剂包括多烯类、唑类和烯丙胺类。它们专门中和真菌和皮肤癣菌,如念珠菌和绦虫,可用于治疗脚气、癣、曲霉病、念珠菌病和真菌性脑膜炎。这些药物以非处方胶囊、凝胶、液体、片剂或滴剂的形式提供,可直接注射到血液中,以最大限度地减少或预防真菌感染。

抗真菌药物市场趋势

  • 真菌感染和医院获得性感染的增加是为市场增长提供光明前景的关键因素之一。抗真菌药物可有效对抗因暴露于受污染的医院表面和潮湿环境而引起的全身和表面感染。此外,城市和农村地区非处方药的易获得性也推动了市场增长。随着公众的健康意识增强,消费者越来越多地选择非处方药来及时治疗轻微感染。此外,各种产品创新,例如用于治疗侵袭性真菌感染的合成和半合成唑类化合物的开发,也在推动增长。此外,製药公司正在大力投资研发具有增强效力的新疗法,例如喷雾剂、乳膏剂、片剂和注射剂。预计推动市场增长的其他因素包括製药行业的快速增长以及政府实施促进公共卫生的有利政策。

主要市场细分

  • IMARC Group 对全球抗真菌药物市场报告的每个子部分的主要趋势进行了分析,并对 2022-2027 年在全球、区域和国家层面的预测进行了分析。该报告根据药物类别和适应症对市场进行分类。

按治疗类别细分

  • 唑类
  • 伏立康唑 (Vfend)
  • 泊沙康唑(诺沙非)
  • 克霉唑(Canesten)
  • 艾沙康唑(克雷森巴)
  • 其他
  • 棘白菌素
  • 卡泊芬净 (Cansidus)
  • Mikafungin (Mikamin/Fanguard)
  • 其他
  • 多烯
  • 两性霉素(Ambisome)
  • 其他
  • 烯丙胺
  • 特比□芬(Lamisil)
  • 其他
  • 其他

按指示细分

  • 皮肤癣菌病
  • 曲霉菌病
  • 念珠菌病
  • 侵袭性念珠菌病
  • 外阴念珠菌病 (VVC)
  • 口腔/咽/食道念珠菌病
  • 其他
  • 其他

按地区细分

  • 北美
  • 美国
  • 加拿大
  • 亚太地区
  • 中国
  • 日本
  • 印度
  • 韩国
  • 澳大利亚
  • 印度尼西亚
  • 其他
  • 欧洲
  • 德国
  • 法国
  • 英国
  • 意大利
  • 西班牙
  • 俄罗斯
  • 其他
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他
  • 中东和非洲

本报告回答的关键问题

  • 到目前为止,全球抗真菌药物市场的表现如何,未来几年又会如何?
  • COVID-19 对全球抗真菌药物市场有何影响?
  • 主要的区域市场有哪些?
  • 基于治疗类别的市场细分是什么?
  • 基于指示的市场细分是什么?
  • 行业价值链的不同阶段有哪些?
  • 行业的主要驱动力和挑战是什么?
  • 全球抗真菌药物市场的结构是什么?主要参与者有哪些?
  • 行业竞争程度如何?

内容

第1章前言

第 2 章研究方法和范围

  • 调查目的
  • 利益相关者
  • 数据来源
    • 主要信息
    • 辅助信息
  • 市场估算
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章执行摘要

第4章介绍

  • 概览
  • 主要工业趋势

第 5 章全球抗真菌药物市场

  • 市场概览
  • 市场结果
  • COVID-19 的影响
  • 市场预测

第 6 章按药物类别划分的市场细分

  • 唑类
    • 市场趋势
    • 主要细分市场
      • 伏立康唑 (Vfend)
      • 泊沙康唑(诺沙非)
      • 克霉唑(Canesten)
      • 艾沙康唑(克雷森巴)
      • 其他
    • 市场预测
  • 棘白菌素
    • 市场趋势
    • 主要细分市场
      • 卡泊芬净 (Cansidus)
      • Mikafungin (Mikamin/Fanguard)
      • 其他
    • 市场预测
  • 多烯
    • 市场趋势
    • 主要细分市场
      • 两性霉素(Ambisome)
      • 其他
    • 市场预测
  • 烯丙胺
    • 市场趋势
    • 主要细分市场
      • 特比□芬(Lamisil)
      • 其他
    • 市场预测
  • 其他
    • 市场趋势
    • 市场预测

第 7 章按指示划分的市场细分

  • 皮肤癣菌病
    • 市场趋势
    • 市场预测
  • 曲霉菌病
    • 市场趋势
    • 市场预测
  • 念珠菌病
    • 市场趋势
    • 主要细分市场
      • 侵袭性念珠菌病
      • 外阴念珠菌病 (VVC)
      • 口腔/咽/食道念珠菌病
      • 其他
    • 市场预测
  • 其他
    • 市场趋势
    • 市场预测

第 8 章按地区划分的市场细分

  • 北美
    • 美国
      • 市场趋势
      • 市场预测
    • 加拿大
      • 市场趋势
      • 市场展望
  • 亚太地区
    • 中国
      • 市场趋势
      • 市场展望
    • 日本
      • 市场趋势
      • 市场预测
    • 印度
      • 市场趋势
      • 市场展望
    • 韩国市场
      • 市场趋势
      • 市场展望
    • 澳大利亚
      • 市场趋势
      • 市场展望
    • 印度尼西亚
      • 市场趋势
      • 市场展望
    • 其他
      • 市场趋势
      • 市场预测
  • 欧洲
    • 德国
      • 市场趋势
      • 市场展望
    • 法国
      • 市场趋势
      • 市场预测
    • 英国
      • 市场趋势
      • 市场预测
    • 意大利
      • 市场趋势
      • 市场展望
    • 西班牙
      • 市场趋势
      • 市场展望
    • 俄罗斯
      • 市场趋势
      • 市场展望
    • 其他
      • 市场趋势
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场趋势
      • 市场展望
    • 墨西哥
      • 市场趋势
      • 市场展望
    • 其他
      • 市场趋势
      • 市场预测
  • 中东和非洲
    • 市场趋势
    • 按国家/地区划分的市场细分
    • 市场展望

第 9 章 SWOT 分析

  • 概览
  • 实力
  • 弱点
  • 机会
  • 威胁

第 10 章价值链分析

第11章搬运工五力分析

  • 概览
  • 买家的议价能力
  • 供应商的议价能力
  • 争用度
  • 新进入者的威胁
  • 替代品的威胁

第 12 章:价格分析

第 13 章竞争格局

  • 市场结构
  • 主要公司
  • 主要公司简介
    • Abbott Laboratories
    • Arcadia Consumer Healthcare Inc.
    • Astellas Pharma Inc.
    • Bayer AG
    • GlaxoSmithKline Plc
    • Merck & Co. Inc.
    • Merck KGaA
    • Novartis AG
    • Pfizer Inc.
    • Sanofi S.A.
    • Scynexis Inc.
Product Code: SR1122A88_Report

The global antifungal drugs market size reached US$ 14.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 17.4 Billion by 2027, exhibiting a growth rate (CAGR) of 3.7% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Antifungal drugs, or antimycotic drugs, refer to the pharmaceutical medicines used for the treatment of fungal infections on skin, hair and nails. Some of the commonly used antifungal drugs include polyenes, azoles and allylamines. They specifically neutralize fungal agents and dermatophytes, such as candida and tapeworms, and aid in the treatment of athlete's foot, ringworm, aspergillosis, candidiasis and fungal meningitis. These drugs are commonly available in over the counter (OTC) capsule, gel, liquid and pill variants or intravenous solutions that are injected directly into the bloodstream to minimize and prevent fungal infection.

Antifungal Drugs Market Trends:

  • The increasing prevalence of fungal and nosocomial infections is one of the key factors creating a positive outlook for the market growth. Antifungal drugs are effective against both systemic and superficial infections that are acquired from exposure to contaminated surfaces in hospitals or humid conditions. Moreover, the convenient availability of OTC drugs in both urban and rural areas is providing a thrust to the market growth. With the rising health consciousness among the masses, consumers are increasingly opting for OTC therapeutics to timely treat minor infections. Additionally, various product innovations, such as the development of synthetic and semi-synthetic azole-based compounds for the treatment of invasive fungal infections, are acting as other growth-inducing factors. Pharmaceutical manufacturers are also investing extensively in the research and development (R&D) of novel therapeutics in the form of sprays, creams, tablets and injections with enhanced efficacy. Other factors, including significant growth in the pharmaceutical industry, along with the implementation of favorable government policies promoting public health, are anticipated to drive the market toward growth.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global antifungal drugs market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on drug class and indication.

Breakup by Drug Class:

  • Azoles
  • Voriconazole (Vfend)
  • Posaconazole (Noxafil)
  • Clotrimazole (Canesten)
  • Isavuconazole (CRESEMBA)
  • Others
  • Echinocandins
  • Caspofungin (Cancidas)
  • Micafungin (Mycamine/ Funguard)
  • Others
  • Polyenes
  • Amphotericin (AmBisome)
  • Others
  • Allylamines
  • Terbinafine (Lamisil)
  • Others
  • Others

Breakup by Indication:

  • Dermatophytosis
  • Aspergillosis
  • Candidiasis
  • Invasive Candidiasis
  • Vulvovaginal Candidiasis (VVC)
  • Mouth/Throat/Esophageal Candidiasis
  • Others
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arcadia Consumer Healthcare Inc., Astellas Pharma Inc., Bayer AG, GlaxoSmithKline Plc, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A. and Scynexis Inc.

Key Questions Answered in This Report:

  • How has the global antifungal drugs market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global antifungal drugs market?
  • What are the key regional markets?
  • What is the breakup of the market based on the drug class?
  • What is the breakup of the market based on the indication?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global antifungal drugs market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Antifungal Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Class

  • 6.1 Azoles
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Voriconazole (Vfend)
      • 6.1.2.2 Posaconazole (Noxafil)
      • 6.1.2.3 Clotrimazole (Canesten)
      • 6.1.2.4 Isavuconazole (CRESEMBA)
      • 6.1.2.5 Others
    • 6.1.3 Market Forecast
  • 6.2 Echinocandins
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Caspofungin (Cancidas)
      • 6.2.2.2 Micafungin (Mycamine/ Funguard)
      • 6.2.2.3 Others
    • 6.2.3 Market Forecast
  • 6.3 Polyenes
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Amphotericin (AmBisome)
      • 6.3.2.2 Others
    • 6.3.3 Market Forecast
  • 6.4 Allylamines
    • 6.4.1 Market Trends
    • 6.4.2 Key Segments
      • 6.4.2.1 Terbinafine (Lamisil)
      • 6.4.2.2 Others
    • 6.4.3 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Indication

  • 7.1 Dermatophytosis
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Aspergillosis
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Candidiasis
    • 7.3.1 Market Trends
    • 7.3.2 Key Segments
      • 7.3.2.1 Invasive Candidiasis
      • 7.3.2.2 Vulvovaginal Candidiasis (VVC)
      • 7.3.2.3 Mouth/Throat/Esophageal Candidiasis
      • 7.3.2.4 Others
    • 7.3.3 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Arcadia Consumer Healthcare Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Astellas Pharma Inc.
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Bayer AG
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 GlaxoSmithKline Plc
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 Merck & Co. Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 Merck KGaA
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Novartis AG
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Pfizer Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Sanofi S.A.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Scynexis Inc.
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials

List of Figures

  • Figure 1: Global: Antifungal Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Antifungal Drugs Market: Sales Value (in Billion US$), 2016-2021
  • Figure 3: Global: Antifungal Drugs Market Forecast: Sales Value (in Billion US$), 2022-2027
  • Figure 4: Global: Antifungal Drugs Market: Breakup by Drug Class (in %), 2021
  • Figure 5: Global: Antifungal Drugs Market: Breakup by Indication (in %), 2021
  • Figure 6: Global: Antifungal Drugs Market: Breakup by Region (in %), 2021
  • Figure 7: Global: Antifungal Drugs (Azoles) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 8: Global: Antifungal Drugs (Azoles) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 9: Global: Antifungal Drugs (Echinocandins) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 10: Global: Antifungal Drugs (Echinocandins) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 11: Global: Antifungal Drugs (Polyenes) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 12: Global: Antifungal Drugs (Polyenes) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 13: Global: Antifungal Drugs (Allylamines) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 14: Global: Antifungal Drugs (Allylamines) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 15: Global: Antifungal Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 16: Global: Antifungal Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 17: Global: Antifungal Drugs (Dermatophytosis) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 18: Global: Antifungal Drugs (Dermatophytosis) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 19: Global: Antifungal Drugs (Aspergillosis) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 20: Global: Antifungal Drugs (Aspergillosis) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 21: Global: Antifungal Drugs (Candidiasis) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 22: Global: Antifungal Drugs (Candidiasis) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 23: Global: Antifungal Drugs (Other Indications) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 24: Global: Antifungal Drugs (Other Indications) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 25: North America: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 26: North America: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 27: United States: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 28: United States: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 29: Canada: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 30: Canada: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 31: Asia-Pacific: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 32: Asia-Pacific: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 33: China: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 34: China: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 35: Japan: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 36: Japan: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 37: India: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 38: India: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 39: South Korea: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 40: South Korea: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 41: Australia: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 42: Australia: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 43: Indonesia: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 44: Indonesia: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 45: Others: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 46: Others: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 47: Europe: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 48: Europe: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 49: Germany: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 50: Germany: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 51: France: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 52: France: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 53: United Kingdom: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 54: United Kingdom: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 55: Italy: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 56: Italy: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 57: Spain: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 58: Spain: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 59: Russia: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 60: Russia: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 61: Others: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 62: Others: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 63: Latin America: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 64: Latin America: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 65: Brazil: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 66: Brazil: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 67: Mexico: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 68: Mexico: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 69: Others: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 70: Others: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 71: Middle East and Africa: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 72: Middle East and Africa: Antifungal Drugs Market: Breakup by Country (in %), 2021
  • Figure 73: Middle East and Africa: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 74: Global: Antifungal Drugs Industry: SWOT Analysis
  • Figure 75: Global: Antifungal Drugs Industry: Value Chain Analysis
  • Figure 76: Global: Antifungal Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Antifungal Drugs Market: Key Industry Highlights, 2021 and 2027
  • Table 2: Global: Antifungal Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2022-2027
  • Table 3: Global: Antifungal Drugs Market Forecast: Breakup by Indication (in Million US$), 2022-2027
  • Table 4: Global: Antifungal Drugs Market Forecast: Breakup by Region (in Million US$), 2022-2027
  • Table 5: Global: Antifungal Drugs Market: Competitive Structure
  • Table 6: Global: Antifungal Drugs Market: Key Players